CAAS Capital Management’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-22,994	Closed	-$52K	–	542
2022 Q4	$52K	Buy	+22,994	New	+$52K	﹤0.01%	378
2021 Q1	–	Sell	-30,000	Closed	-$796K	–	995
2020 Q4	$796K	Hold	30,000	–	–	0.01%	315
2020 Q3	$672K	Buy	+30,000	New	+$672K	0.02%	206